Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults

OBJECTIVES: In Canada, incidences of herpes zoster (HZ) and postherpetic neuralgia (PHN) are increasing, posing a significant burden on the healthcare system. This study aimed to determine the public health impact and cost effectiveness of an adjuvanted recombinant zoster vaccine (RZV) compared to n...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Appl Health Econ Health Policy
Huvudupphovsmän: McGirr, Ashleigh, Van Oorschot, Desiree, Widenmaier, Robyn, Stokes, Michael, Ganz, Michael L., Jung, Hyosung, Varghese, Lijoy, Curran, Desmond
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer International Publishing 2019
Ämnen:
Original Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6748891/
https://ncbi.nlm.nih.gov/pubmed/31250218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40258-019-00491-6
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk